Zongle Therapeutics
Natural health product licensed in Canada
- Licence holder
- Zongle Therapeutics
- NPN or DIN-HM
- 80097237
- Status
- Active licence
- Licence date
- 24 February 2020
- Revision date
- Not provided
- Form
- Huile
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Citrus paradisi Source : Pelure (fruit) | 100 % |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | Not specified | Not specified |
Uses authorised in Canada
Used in aromatherapy as a carminative/antispasmodic for symptomatic relief of digestive discomfort. Used in aromatherapy to relieve minor skin irritation/cuts/bruises/burns.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Avoid contact with eyes, inner ears, and sensitive areas. If pregnant, nursing, or under a doctor's care, consult your physician. Possible skin sensitivity. Keep out of reach of children.
Source
Official Health Canada record, licence 80097237
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.